Citigroup
ONCE

Citigroup’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Citigroup’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,600
Closed -$80K – 7423
2016
Q4 		$80K Buy
+1,600
New +$85.7K ﹤0.01% 5905
2016
Q3 		– Sell
-100,000
Closed -$5.11M – 7273
2016
Q2 		$5.11M Buy
+100,000
New +$4.27M 0.01% 1572

Citigroup's ONCE Position: Q4 2019 in Review

Citigroup sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 33,672 shares — an estimated $3.27M sold.

Citigroup first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $25.2M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Citigroup reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Citigroup sold 33,672 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $3.27M.
  • Citigroup first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
  • Citigroup's Spark Therapeutics, Inc. Common Stock position peaked at $25.2M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.